Table 1.
DRUG | N | Mean | Std. Deviation | Std.Error Mean | |
---|---|---|---|---|---|
AC250 | Drop Table | 40 32 |
+6.8750 -0.9375 |
12.0728 6.8906 |
1.9089 1.2181 |
AC500 | Drop Table | 40 32 |
-0.1250 +1.0938 |
10.5300 6.6883 |
1.6649 1.1823 |
AC1000 | Drop Table | 40 32 |
-1.3750 +1.0938 |
8.2421 9.6499 |
1.3032 1.7059 |
AC2000 | Drop Table | 40 32 |
+3.5000 +4.6875 |
11.0477 6.3421 |
1.7468 1.11211 |
AC4000 | Drop Table | 40 32 |
+2.2500 +1.8750 |
11.091 7.4865 |
1.7537 1.3234 |
AC8000 | Drop Table | 40 32 |
+5.5000 -1.2500 |
14.4939 10.8509 |
2.2913 1.9182 |
AC10000 | Drop Table | 40 32 |
+6.2500 +0.9375 |
12.4936 6.7725 |
1.9754 1.1972 |
AC12000 | Drop Table | 40 32 |
+4.2500 +3.9063 |
9.9066 5.3483 |
1.5664 0.9454 |
Based on this table the improvement of hearing thresholds at frequencies of 250, 8000, 1000, in air conduction for the group receiving drops is significant compared to the group receiving oral intake.
250 T=0.325 Significance 0.02 p<0.05 frequency
8000 T= 2.188 Significance 0.032 p<0.05 frequency
10000 T-2.163 Significance 0.034 p<0.05 frequency
In other frequencies symptoms for the sake of hearing loss was not seen in both groups significantly.